Combined dehydroepiandrosterone and retinoid therapy for epithelial disorders
US6093706A · kind A · utility
37Cited by
4References
57Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 4, 1992 |
| Grant date | Jul 25, 2000 |
| Priority date | — |
| Expiry date | Mar 4, 2012 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S977/915
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions and methods for the treatment of oxidative epithelial damage, for inadequate surfactant production in lung disorders, and for disorders of the urinary bladder epithelium. The compositions of the present invention comprise dehydroepiandrosterone and vitamin A derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.